Contract facts
FederalNo full NAICS 541712 intel page yet. Browse NAICS intelligence
SIMIAN VACCINE EVALUATION UNITS is a federal award for National Institutes Of Health Niaid held by Advanced Bioscience Laboratories, Inc. Estimated value $34.9M ($1.2M obligated). Current period of performance ends Dec 31, 2026. Last award drew 6 bidders. Place of performance: ROCKVILLE, MD. Related solicitation NIAID DAIDS NIHAI2012138.
Recompete timing
PublicCurrent PoP ends Dec 31, 2026 (133 days remaining). Agencies typically plan 12–18 months ahead — at 4.4 months out, that window is already open. The buying decision is likely already in motion.
Incumbent footprint
Public recordAdvanced Bioscience Laboratories, Inc — $41.8M obligated across 70 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract HHSN27200002?
HHSN27200002 (SIMIAN vaccine evaluation UNITS) is a National Institutes Of Health Niaid award with an estimated value of $34.9M, currently held by Advanced Bioscience Laboratories, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded HHSN27200002?
National Institutes Of Health Niaid awarded HHSN27200002 to Advanced Bioscience Laboratories, Inc.
Who is the incumbent on HHSN27200002?
Advanced Bioscience Laboratories, Inc is the incumbent with $41.8M across 70 related awards in SCOUT’s public footprint. The current period of performance ends Dec 31, 2026.
When does Advanced Bioscience Laboratories, Inc’s HHSN27200002 come up for recompete?
SCOUT tracks a period-of-performance end of Dec 31, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.